Dopaminergic treatments are associated with impulse control disorders such as pathological gambling in a subset of patients with Parkinson's Disease. While deep brain stimulation of the subthalamic nucleus has been reported to reduce symptoms of impulse control disorders in some Parkinson's Disease patients, little is known about its specific effects on gambling behaviour. In this experiment, we investigated the effects of deep brain stimulation of the subthalamic nucleus on one of the central features of pathological gambling: the tendency to chase losses. Loss-chasing is associated with impaired control over gambling behaviour and it is one of the most salient features of pathological gambling as it presents in the clinic. Twenty two pati...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson’s disease is known to cause a s...
Pathological gambling develops in up to 8% of patients with Parkinson's disease. Although the pathop...
Dopaminergic treatments are associated with impulse control disorders such as pathological gambling ...
Dopaminergic treatments are associated with impulse control disorders such as pathological gambling ...
BACKGROUND: Impulse control disorders (ICD), including pathological gambling, are common in Parkinso...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson's disease is known to cause a s...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson's disease is known to cause a s...
Item does not contain fulltextBACKGROUND: Impulse control disorders (ICD), including pathological ga...
Pathological gambling (PG) is an impulse control disorder that manifests in 2.2\u20137% of patients ...
Pathological gambling develops in up to 8% of patients with Parkinson's disease. Although the pathop...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson’s disease is known to cause a s...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson’s disease is known to cause a s...
Pathological gambling develops in up to 8% of patients with Parkinson's disease. Although the pathop...
Dopaminergic treatments are associated with impulse control disorders such as pathological gambling ...
Dopaminergic treatments are associated with impulse control disorders such as pathological gambling ...
BACKGROUND: Impulse control disorders (ICD), including pathological gambling, are common in Parkinso...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson's disease is known to cause a s...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson's disease is known to cause a s...
Item does not contain fulltextBACKGROUND: Impulse control disorders (ICD), including pathological ga...
Pathological gambling (PG) is an impulse control disorder that manifests in 2.2\u20137% of patients ...
Pathological gambling develops in up to 8% of patients with Parkinson's disease. Although the pathop...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson’s disease is known to cause a s...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
International audiencePathological gambling (PG) related to dopaminergic treatment in Parkinson's di...
Deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson’s disease is known to cause a s...
Pathological gambling develops in up to 8% of patients with Parkinson's disease. Although the pathop...